Correspondence

Response to the ACMD's report on xylazine and related compounds

Government response to the report by the Advisory Council on the Misuse of Drugs on xylazine, medetomidine and detomidine.

• From: Home Office, Advisory Council on the Misuse of Drugs, and The Rt Hon Chris Philp MP
• Published: 21 March 2024

Documents

Government response to the ACMD’s advice on xylazine and related compounds

HTML

Details

The government responds to a report by the Advisory Council on the Misuse of Drugs (ACMD) regarding the harms of xylazine and related compounds.

Published 21 March 2024